Recurrent Loss-Of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates

Cell Host and Microbe - United States
doi 10.1016/j.chom.2019.01.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Loss-Of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy

American Journal of Human Genetics
Genetics
2016English

Loss-Of-Function Mutations in Sodium Channel Nav1.7 Cause Anosmia

Nature
Multidisciplinary
2011English

Bi-Allelic Loss-Of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia

American Journal of Human Genetics
Genetics
2019English

Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Homozygous Loss-Of-Function Mutations in SLC26A7 Cause Goitrous Congenital Hypothyroidism

Yearbook of Paediatric Endocrinology
2019English

Effects of MYBPC3 Loss of Function Mutations Preceding Hypertrophic Cardiomyopathy

JCI insight
Medicine
2020English

Making Sense of CBP/P300 Loss of Function Mutations in Skin Tumorigenesis

Journal of Pathology
Forensic MedicinePathology
2019English

BMP4 Loss-Of-Function Mutations in Developmental Eye Disorders Including SHORT Syndrome

Human Genetics
Genetics
2011English

Loss-Of-Function Mutations in HPSE2 Cause the Autosomal Recessive Urofacial Syndrome

American Journal of Human Genetics
Genetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy